NCT03956615 · OUTCOME

Fraction of Patients (n=3) for Whom a sdAb Could be Generated That Binds to the Idiotype of the Paraprotein.

sdAb-based TRNT of Multiple Myeloma: a Feasibility Study · Source last updated 2021-12-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

What was measured

Reporting of the relative amount of patients for whom such sdAb could be successfully obtained

Analysis population: Out of 10 patients included, three patients with confirmed surface Ig expression were selected for sdAb generation.

Only 1 arm/group in this trial

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Patients With a Clinically Suspected or Pathologically Confirmed Multiple Myeloma.	3

Source class 1

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Patients With a Clinically Suspected or Pathologically Confirmed Multiple Myeloma.	2	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

denoms

description

Reporting of the relative amount of patients for whom such sdAb could be successfully obtained

groups

param Type

COUNT_OF_PARTICIPANTS

population Description

Out of 10 patients included, three patients with confirmed surface Ig expression were selected for sdAb generation.

reporting Status

POSTED

time Frame

Within 2 years after study completion

title

Fraction of Patients (n=3) for Whom a sdAb Could be Generated That Binds to the Idiotype of the Paraprotein.

type

PRIMARY

unit Of Measure

Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice